tirzepatide trial FDA Approves Tirzepatide, A Potential Blockbuster Drug for Type 2 Diabetes Tirzepatide monotherapy in Chinese patients

Dietetics 30, 753758

Wegovy cannot be used in patients with a personal or family history of MEN 2 (Multiple Endocrine Neoplasia Syndrome type 2) or medullary thyroid cancer (MTC)

Supplement Facts: Serving Size: 1 scoop (26g) Servings Per Container: 15 Amount Per Serving: Energy kJ: 365 kJ Energy kcal: 86 kcal Fat: 0.03 g of which saturates: 0.03 g Carbohydrate: 1.4 g of which sugars: 0.39 g Protein: 20 g Salt: 0.47 g *RI - Reference Intake Ingredients: Hydrolysed whey protein concentrate Lacprodan HYDRO.365 (from milk), flavourings, acidity regulators (E330, E334), salt, anti-caking agent (E551), sweeteners (sucralose, acesulfame K, steviol glycosides from Stevia), red beet juice concentrate, colour [(E160a), (E150c)]

Neither is automatically 'better'